Three hundred and nineteen adolescents aged 10–12 years who had been previously
vaccinated with five doses of acellular pertussis-containing vaccines received single doses …

We compared immunogenicity and reactogenicity of a single dose of DTaP vaccine
(containing tetanus and diphtheria toxoids and four acellular pertussis antigens) with …

High rates of pertussis disease in adolescents suggest that additional boosting against
pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine …

OBJECTIVE: The safety of a booster dose of a reduced-antigen-content tetanus–diphtheria–
acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with …

Background Increasing evidence shows that protection induced by acellular pertussis
vaccines is short-lived, requiring repeated booster vaccination to control pertussis disease …

Persistence of antibodies following a single dose of Tdap vaccine (tetanus, diphtheria, and
five-component acellular pertussis vaccine for use in individuals past childhood) was …

BACKGROUND: Annual influenza vaccination provides an opportunity to administer a
booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine …

Thailand has incorporated the whole-cell (wP) pertussis vaccine into the expanded program
on immunization since 1977 and has offered the acellular pertussis (aP) vaccine as an …

Abstract▲ Boostrix® US formulation (hereafter referred to as Tdap) is a formulation of
reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto …

Patients with obstructive airway diseases (OAD), like chronic obstructive pulmonary disease
(COPD) and asthma, may be at increased risk of pertussis infection. Pertussis may also …